167 related articles for article (PubMed ID: 14712316)
1. Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.
Rohr UP; Wulf MA; Stahn S; Heyd F; Steidl U; Fenk R; Opalka B; Pitschke G; Prisack HB; Bojar H; Haas R; Kronenwett R
Cancer Gene Ther; 2003 Dec; 10(12):898-906. PubMed ID: 14712316
[TBL] [Abstract][Full Text] [Related]
2. Additional gene therapy with rAAV-wt-p53 enhanced the efficacy of cisplatin in human bladder cancer cells.
Ruifa H; Liwei L; Binxin L; Ximing L
Urol Int; 2006; 77(4):355-61. PubMed ID: 17135787
[TBL] [Abstract][Full Text] [Related]
3. Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector.
Vermeij J; Zeinoun Z; Neyns B; Teugels E; Bourgain C; De Grève J
Br J Cancer; 2001 Nov; 85(10):1592-9. PubMed ID: 11720450
[TBL] [Abstract][Full Text] [Related]
4. Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53.
Qazilbash MH; Xiao X; Seth P; Cowan KH; Walsh CE
Gene Ther; 1997 Jul; 4(7):675-82. PubMed ID: 9282168
[TBL] [Abstract][Full Text] [Related]
5. Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells.
Buttgereit P; Schakowski F; Märten A; Brand K; Renoth S; Ziske C; Schöttker B; Ebert O; Schroers R; Schmidt-Wolf IG
Cancer Gene Ther; 2001 Jun; 8(6):430-9. PubMed ID: 11498763
[TBL] [Abstract][Full Text] [Related]
6. Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis.
Gu J; Zhang L; Swisher SG; Liu J; Roth JA; Fang B
Oncogene; 2004 Feb; 23(6):1300-7. PubMed ID: 14676844
[TBL] [Abstract][Full Text] [Related]
7. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
Cheng J; Leng X; Peng J
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
[TBL] [Abstract][Full Text] [Related]
8. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
9. The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells.
Neukirchen J; Meier A; Rohrbeck A; Garcia-Pardillos G; Steidl U; Fenk R; Haas R; Kronenwett R; Rohr UP
Cancer Gene Ther; 2007 Apr; 14(4):431-9. PubMed ID: 17235352
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells.
Yang CT; Li JM; Weng HH; Li YC; Chen HC; Chen MF
Cancer Gene Ther; 2010 Feb; 17(2):120-30. PubMed ID: 19730451
[TBL] [Abstract][Full Text] [Related]
11. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.
Boulay JL; Perruchoud AP; Reuter J; Bolliger C; Herrmann R; Rochlitz C
Cancer Gene Ther; 2000 Sep; 7(9):1215-9. PubMed ID: 11023193
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.
Roth JA; Swisher SG; Merritt JA; Lawrence DD; Kemp BL; Carrasco CH; El-Naggar AK; Fossella FV; Glisson BS; Hong WK; Khurl FR; Kurie JM; Nesbitt JC; Pisters K; Putnam JB; Schrump DS; Shin DM; Walsh GL
Semin Oncol; 1998 Jun; 25(3 Suppl 8):33-7. PubMed ID: 9704675
[TBL] [Abstract][Full Text] [Related]
13. E1B-deleted adenovirus replicates in p53-deficient lung cancer cells due to the absence of apoptosis.
Harada N; Maniwa Y; Yoshimura M; Nagata M; Hamada H; Yokono K; Okita Y
Oncol Rep; 2005 Nov; 14(5):1155-63. PubMed ID: 16211279
[TBL] [Abstract][Full Text] [Related]
14. ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.
You L; Yang CT; Jablons DM
Cancer Res; 2000 Feb; 60(4):1009-13. PubMed ID: 10706117
[TBL] [Abstract][Full Text] [Related]
15. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis.
Fujiwara T; Grimm EA; Mukhopadhyay T; Cai DW; Owen-Schaub LB; Roth JA
Cancer Res; 1993 Sep; 53(18):4129-33. PubMed ID: 8395976
[TBL] [Abstract][Full Text] [Related]
16. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
Maemondo M; Saijo Y; Narumi K; Kikuchi T; Usui K; Tazawa R; Matsumoto K; Nakamura T; Sasaki K; Takahashi M; Niitsu Y; Nukiwa T
Cancer Res; 2004 Jul; 64(13):4611-20. PubMed ID: 15231673
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS
J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells.
Horio Y; Hasegawa Y; Sekido Y; Takahashi M; Roth JA; Shimokata K
Cancer Gene Ther; 2000 Apr; 7(4):537-44. PubMed ID: 10811471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
